David Martínez Briseño

Mr. David Martínez Briseño

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in ERJ Open Research
Verified
Journal Article
Open access
PDF file
LGLaura Gochicoa-Rangel
Laura Gochicoa-Rangel
DBDavid Martínez Briseño
David Martínez Briseño
SGSelene Guerrero-Zúñiga
Selene Guerrero-Zúñiga
JCJessica Contreras-Morales
Jessica Contreras-Morales
DADulce Arias-Jiménez
Dulce Arias-Jiménez
MVMario H. Vargas
Mario H. Vargas
Background: Published reference equations for impulse oscillometry (IOS) usually encompass a specific age group but not the entire lifespan. This may lead to discordant predicted values when two or more non-coincident equations can be applied to the same person, or when a person moves from one equation to the next non-convergent equation as he or she gets older. Thus, our aim was to provide a single reference equation for each IOS variable that could be applied from infancy to old age.Methods: This was an ambispective cross-sectional study in healthy nonsmokers, most of whom lived in Mexico City, who underwent IOS according to international standards. A multivariate piecewise linear regression, also known as segmented regression, was used to obtain reference equations for each IOS variable.Results: In a population of 830 subjects (54.0% female) aged 2.7 to 90 years (54.8% children ≤12 years), segmented regression estimated two breakpoints for age in almost all IOS variables, except for R5−R20 in which only one breakpoint was detected. With this approach, multivariate regressions including sex, age, height and body mass index as independent variables were constructed, and coefficients for calculating predicted value, lower and upper limits of normal, percentage of predicted and z-score were obtained.Conclusions: Our study provides IOS reference equations that include the major determinants of lung function,i.e.sex, age, height and body mass index, that can be easily implemented for subjects of almost any age.

23 August 2022 in Viruses
Verified
Journal Article
Open access
PDF file
RPRosario Fernandez Plata
Rosario Fernandez Plata
AHAnjarath Lorena Higuera-Iglesias
Anjarath Lorena Higuera-Iglesias
LTLuz-María Torres-Espíndola
Luz-María Torres-Espíndola
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
RVRafael Velazquez-Cruz
Rafael Velazquez-Cruz
RGResearch Working Group
Research Working Group
Background: Infection by SARS-CoV-2 has been associated with multiple symptoms; however, still, little is known about persistent symptoms and their probable association with the risk of developing pulmonary fibrosis in patients post-COVID-19. Methods: A longitudinal prospective study on health workers infected by SARS-CoV-2 was conducted. In this work, signs and symptoms were recorded of 149 health workers with a positive PCR test for SARS-CoV-2 at the beginning of the diagnosis, during the active infection, and during post-COVID-19 follow-up. The McNemar chi-square test was used to compare the proportions and percentages of symptoms between the baseline and each follow-up period. Results: The signs and symptoms after follow-up were cardiorespiratory, neurological, and inflammatory. Gastrointestinal symptoms were unusual at the disease onset, but unexpectedly, their frequency was higher in the post-infection stage. The multivariate analysis showed that pneumonia (HR 2.4, IC95%: 1.5–3.8, p < 0.001) and positive PCR tests still after four weeks (HR 5.3, IC95%: 2.3-12.3, p < 0.001) were factors associated with the diagnosis of post-COVID-19 pulmonary fibrosis in this study group. Conclusions: Our results showed that pneumonia and virus infection persistence were risk factors for developing pulmonary fibrosis post-COVID-19, after months of initial infection.

14 October 2024 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
LGLaura Gochicoa-Rangel
Laura Gochicoa-Rangel
ADAda De-Los-Santos-Martínez
Ada De-Los-Santos-Martínez
ARAlejandro Reyes-García
Alejandro Reyes-García
DBDavid Martínez Briseño
David Martínez Briseño
MVMario H Vargas
Mario H Vargas
GZGerald Stanley Zavorsky
Gerald Stanley Zavorsky
Objectives: This study aimed to evaluate pulmonary diffusing capacity for nitric oxide (DLNO) and pulmonary diffusing capacity for carbon monoxide (DLCO) in Mexican Hispanics born and raised at 2240 m altitude (midlanders) compared with those born and raised at sea level (lowlanders). It also aimed to assess the effectiveness of race-specific reference equations for pulmonary diffusing capacity (white people vs Mexican Hispanics) in minimising root mean square errors (RMSE) compared with race-neutral equations. Methods: DLNO, DLCO, alveolar volume (VA) and gas transfer coefficients (KNO and KCO) were measured in 392 Mexican Hispanics (5 to 78 years) and compared with 1056 white subjects (5 to 95 years). Reference equations were developed using segmented linear regression (DLNO, DLCO and VA) and multiple linear regression (KNO and KCO) and validated with Least Absolute Shrinkage and Selection Operator. RMSE comparisons between race-specific and race-neutral models were conducted using repeated k-fold cross-validation and random forests. Results: Midlanders exhibited higher DLCO (mean difference: +4 mL/min/mm Hg), DLNO (mean difference: +7 mL/min/mm Hg) and VA (mean difference: +0.17 L) compared with lowlanders. The Bayesian information criterion favoured race-specific models and excluding race as a covariate increased RMSE by 61% (DLNO), 18% (DLCO) and 4% (KNO). RMSE values for VA and KCO were comparable between race-specific and race-neutral models. For DLCO and DLNO, race-neutral equations resulted in 3% to 6% false positive rates (FPRs) in Mexican Hispanics and 20% to 49% false negative rates (FNRs) in white subjects compared with race-specific equations. Conclusions: Mexican Hispanics born and raised at 2240 m exhibit higher DLCO and DLNO compared with lowlanders. Including race as a covariate in reference equations lowers the RMSE for DLNO, DLCO and KNO and reduces FPR and FNR compared with race-neutral models. This study highlights the need for altitude-specific and race-specific reference equations to improve pulmonary function assessments across diverse populations.

1 October 2019 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
RFRosario Fernández-Plata
Rosario Fernández-Plata
RPRogelio Pérez-Padilla
Rogelio Pérez-Padilla
RRRodrigo Del Río-Hidalgo
Rodrigo Del Río-Hidalgo
CGCecilia García-Sancho
Cecilia García-Sancho
LGLaura Gochicoa-Rangel
Laura Gochicoa-Rangel
DBDavid Martínez Briseño
David Martínez Briseño

19 April 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
LGLaura Gochicoa-Rangel
Laura Gochicoa-Rangel
KRKeylin Yaoska Rodríguez-Peralta
Keylin Yaoska Rodríguez-Peralta
AGAna Karen Gutiérrez-Bautista
Ana Karen Gutiérrez-Bautista
CGCarlos Guzmán-Valderrábano
Carlos Guzmán-Valderrábano
RFRosario Fernández-Plata
Rosario Fernández-Plata
DBDavid Martínez Briseño
David Martínez Briseño
Peak inspiratory and expiratory flows (PIF, PEF) are parameters used to evaluate the mechanics of the respiratory system. These parameters can vary based on whether they are measured using mechanical devices vs. spirometry and based on the barometric pressure at which the measurements are obtained. Our objectives were (1) to report the normal values and variability of PEF and PIF of a Latin American population living at a moderate altitude (2240 m above sea level), (2) to analyze the adjustment of reference values obtained at sea level with those obtained in healthy subjects living at a moderate altitude, and (3) to assess the correlation between PEF obtained by spirometry (PEFs) and PEF obtained by mechanical devices (PEFm). In this prospective and transversal study, men and women with good respiratory health aged between 2.8 and 68 years old were invited to participate. Randomly, they underwent spirometry (to measure PEFs and PIFs) and mechanical flowmetry (to measure PEFm). A total of 314 subjects participated, with an average age of 24.3 ± 16.4 years; 59% were Women. The main determinants for the reference equations were age, weight, height and sex at birth. The agreement of the PEFm, PEFs and PIFs values was inconsistent with that reported by other authors, even at the same barometric pressure. The association between PEFm and PEFs was r = 0.91 (p < 0.001), and the correlation coefficient of concordance was 0.84. The PEFm, PEFs, and PIFs measurements in individuals living at moderate altitudes are different from those found by other authors in cities with different barometric pressures and ethnicities.

Verified
Journal Article
Open access
PDF file
DPDaniel Paz-Gomez
Daniel Paz-Gomez
MLManuel de Jesus Castillejos López
Manuel de Jesus Castillejos López
Yair RomeroYair Romero
Yair Romero
EFEdgar Flores-Soto
Edgar Flores-Soto
BRBianca Romero-Martinez
Bianca Romero-Martinez
AAArnoldo Aquino-Gálvez
Arnoldo Aquino-Gálvez
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease with limited therapeutic options. This review focuses on the role of retinoids, particularly all-trans retinoic acid (atRA), and hypoxia in the pathogenesis of IPF. Despite an established understanding of genetic and environmental factors in IPF, the interplay between retinoid signaling and the response to hypoxia remains poorly explored due to its complexity. Preclinical evidence suggests that atRA could help reduce pulmonary fibrosis by modulating TGF-β signaling pathways and epithelial-to-mesenchymal transition (EMT). Additionally, we mention other diseases where a relationship between hypoxia and retinoids has been observed. We review how hypoxia, a key factor in the progression of IPF, may influence the efficacy of retinoid therapy. Combination strategies are explored to overcome hypoxia-induced treatment resistance. Finally, we address the complex role of retinoids in lung regeneration, balancing their potential benefits against the risk of exacerbating fibrotic processes. This review suggests that retinoids have potential as a treatment or adjuvant for IPF and highlights the need for further research to elucidate the precise mechanisms of retinoid action in IPF, particularly in hypoxia.